Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: positive opinion from CHMP on Tecentriq

( - Roche has announced that the CHMP of the European Medicines Agency has recommended the approval of its Tecentriq, in combination with Avastin, for the treatment of adults with advanced or unresectable hepatocellular carcinomas.

Based on this recommendation, a final decision on the approval of Tecentriq in this combination and for this disease, with full details of the approved indication, is expected from the European Commission in the near future.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.